Cleared Traditional

K182181 - Persyst 14 EEG Review and Analysis Software

K182181 is an FDA 510(k) clearance for Persyst 14 EEG Review and Analysis Software, manufactured by Persyst Development Corporation. The device is a Class 2 Neurology device with product code OMB cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K182181 · Persyst Development Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
108d
Days
Class 2
Risk

K182181 is an FDA 510(k) clearance for the Persyst 14 EEG Review and Analysis Software. Classified as Automatic Event Detection Software For Full-montage Electroencephalograph (product code OMB), Class II - Special Controls.

Submitted by Persyst Development Corporation (Solana Beach, US). The FDA issued a Cleared decision on November 29, 2018 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Persyst Development Corporation devices

FDA 510(k) Submission Details - K182181

510(k) Number K182181 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2018
Decision Date November 29, 2018
Days to Decision 108 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 148d · This submission: 108d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OMB Device Classification - Class 2, Special Controls

Product Code OMB Automatic Event Detection Software For Full-montage Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OMB Automatic Event Detection Software For Full-montage Electroencephalograph

All 22
Devices cleared under the same product code (OMB) and FDA review panel - the closest regulatory comparables to K182181.
Encevis
K211452 · Austrian Institute of Technology GmbH · Dec 2021
Natus NeuroWorks
K200878 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · May 2020
Ceribell Pocket EEG Device
K191301 · Ceribell, Inc. · Sep 2019
encevis
K171720 · Ait Austrian Institute of Technology GmbH · Apr 2018
Natus NeuroWorks
K180421 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · Mar 2018
XLTEK CONNEX IP HEADBOX, MODEL 1054
K042223 · Excel Tech. , Ltd. · Sep 2004